EquityZen Growth Technology Fund LLC - Series 44
Raised
$360K
Investors
12
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 44 is a Delaware pooled investment fund that raised $360K from 12 investors under Rule 506(b) and Section 3(c)(1). Filed by Inc. Equity Zen and related officers in August 2016, this is part of the EquityZen pre-IPO platform, which operates nearly 1,900 related EDGAR entities facilitating secondary market transactions in private company shares.
This pre-IPO vehicle uses the standard 506(b)/3(c)(1) exemption pattern typical of private fund offerings to accredited investors. The $30K average investor commitment suggests relatively accessible pre-IPO exposure compared to institutional-only offerings, consistent with EquityZen's platform model of fractionalized access to late-stage private companies.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Equity Zen Inc.
Executive Officer, Director · New York, NY
Shriram Bhasyam
Executive Officer, Director · New York, NY
Assure Fund Management II LLC
Director · Salt Lake City, UT
Jens Beyrich
Executive Officer · Salt Lake City, UT
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.